Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Heinrich

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Der Urologe. Ausg. A|May 26, 2018
["Integrity" in the healthcare system : Recognize and avoid risks: on dealing with the Association of Statutory Health Insurance Physicians and the public prosecutors office]Martin Wohlgemuth, Julia Heinrich
Reproduction (Cambridge, England)|November 12, 2015
Blood-testis barrier and Sertoli cell function: lessons from SCCx43KO miceJonathan Gerber, Julia Heinrich, Ralph Brehm
Bioanalysis|March 8, 2012
Mathematical simulations for bioanalytical assay development: the (un-)necessity and (im-)possibility of free drug quantificationRoland F Staack, Gregor Jordan, Julia Heinrich
Analytical Biochemistry|September 1, 2012
Generic anti-drug antibody assay with drug tolerance in serum samples from mice exposed to human antibodiesKay Stubenrauch, Klaus Mackeben, Rudolf Vogel, et al.
Bioanalysis|November 28, 2013
Free analyte QC concept: a novel approach to prove correct quantification of free therapeutic protein drug/biomarker concentrationsRoland F Staack, Gregor Jordan, Uwe Dahl, et al.
Bioanalysis|September 28, 2017
Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the 'free analyte QC concept'Gregor Jordan, Ichio Onami, Julia Heinrich, et al.
Bioanalysis|January 21, 2017
3-(4-Hydroxyphenyl)propionic acid: the forgotten detection substrate for ligand-binding assay-based bioanalysisGregor Jordan, Kay-Gunnar Stubenrauch, Julia Heinrich, et al.
Bioanalysis|March 16, 2016
Platform switching from ELISA to Gyrolab™: a novel generic reagent omits the need to change critical reagentsGregor Jordan, Miriam Moheysen-Zadeh, Julia Heinrich, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 22, 2015
Epitope characterization of the ADA response directed against a targeted immunocytokineKay Stubenrauch, Christian Künzel, Rudolf Vogel, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 29, 2012
Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samplesKay Stubenrauch, Uwe Wessels, Ulrich Essig, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Der Urologe. Ausg. A|May 26, 2018
["Integrity" in the healthcare system : Recognize and avoid risks: on dealing with the Association of Statutory Health Insurance Physicians and the public prosecutors office]Martin Wohlgemuth, Julia Heinrich
Reproduction (Cambridge, England)|November 12, 2015
Blood-testis barrier and Sertoli cell function: lessons from SCCx43KO miceJonathan Gerber, Julia Heinrich, Ralph Brehm
Bioanalysis|March 8, 2012
Mathematical simulations for bioanalytical assay development: the (un-)necessity and (im-)possibility of free drug quantificationRoland F Staack, Gregor Jordan, Julia Heinrich
Analytical Biochemistry|September 1, 2012
Generic anti-drug antibody assay with drug tolerance in serum samples from mice exposed to human antibodiesKay Stubenrauch, Klaus Mackeben, Rudolf Vogel, et al.
Bioanalysis|November 28, 2013
Free analyte QC concept: a novel approach to prove correct quantification of free therapeutic protein drug/biomarker concentrationsRoland F Staack, Gregor Jordan, Uwe Dahl, et al.
Bioanalysis|September 28, 2017
Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the 'free analyte QC concept'Gregor Jordan, Ichio Onami, Julia Heinrich, et al.
Bioanalysis|January 21, 2017
3-(4-Hydroxyphenyl)propionic acid: the forgotten detection substrate for ligand-binding assay-based bioanalysisGregor Jordan, Kay-Gunnar Stubenrauch, Julia Heinrich, et al.
Bioanalysis|March 16, 2016
Platform switching from ELISA to Gyrolab™: a novel generic reagent omits the need to change critical reagentsGregor Jordan, Miriam Moheysen-Zadeh, Julia Heinrich, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 22, 2015
Epitope characterization of the ADA response directed against a targeted immunocytokineKay Stubenrauch, Christian Künzel, Rudolf Vogel, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 29, 2012
Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samplesKay Stubenrauch, Uwe Wessels, Ulrich Essig, et al.
Pageof 3